(Q40255867)

18 September 2017

title

Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity (English)

1 reference

18 September 2017

U'Ren L

1

1 reference

18 September 2017

Kedl R

series ordinal

2

1 reference

18 September 2017

Dow S

series ordinal

3

1 reference

18 September 2017

publication date

14 July 2006

1 reference

18 September 2017

1 reference

18 September 2017

volume

13

1 reference

18 September 2017

issue

11

1 reference

18 September 2017

page(s)

1033-1044

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700982

18 September 2017

exact match

0 references

cites work

DNA vaccination against tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

GM-CSF-based cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Dendritic cell immunotherapy: mapping the way.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Cytokine-secreting tumor cell vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Design and evaluation of antigen-specific vaccination strategies against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Therapeutic vaccination for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

The promise of nucleic acid vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Plasmid DNA vaccines against cancer: cytotoxic T-lymphocyte induction against tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

DNA vaccines to attack cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Tumor immunity and autoimmunity induced by immunization with homologous DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Exposing the immunology of naked DNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Systemic gene expression after intravenous DNA delivery into adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Cationic liposome-mediated intravenous gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Improved DNA: liposome complexes for increased systemic delivery and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Accurate identification of experimental pulmonary metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Constitutive class I-restricted exogenous presentation of self antigens in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Phase I study of liposome-DNA complexes encoding the interleukin-2 gene in dogs with osteosarcoma lung metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Early interaction of Yersinia pestis with APCs in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Recent developments in vaccine delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

A role for liposomes in genetic vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Immunoadjuvant action of plasmid DNA in liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Co-delivery of IL-2 or liposomes augment the responses of mice to a DNA vaccine for pseudorabies virus IE180.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Liposome-mediated DNA vaccination: the effect of vesicle composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

On the mechanism of cationic amphiphile-mediated transfection. To fuse or not to fuse: is that the question?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

Peptide-based cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

1 reference

7 January 2021

Dendritic cell-based vaccines in cancer immunotherapy: an update on clinical and immunological results.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

7 January 2021

Phase I study of a plasmid DNA vaccine encoding MART-1 in patients with resected melanoma at risk for relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

7 January 2021

Induction of tumor antigen-specific immunity using plasmid DNA immunization in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

7 January 2021

Type I interferons potently suppress gene expression following gene delivery using liposome(-)DNA complexes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

7 January 2021

Macrophage activation by a DNA/cationic liposome complex requires endosomal acidification and TLR9-dependent and -independent pathways.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

7 January 2021

Liposome-DNA complexes infused intravenously inhibit tumor angiogenesis and elicit antitumor activity in dogs with soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700982

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700982

1 reference

Dimensions Publication ID

18 September 2017

1045660372

0 references

1 reference